Latest Articles
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical - 아시아경제
LG Chem Introduces Endometriosis Treatment 'Dinagest' from Japan's Mochida Pharmaceutical 아시아경제
Published: April 2, 2026, 11:40 p.m.
DKSH Thailand and Bayer Thai Expand Strategic Partnership to Broaden Access to Endometriosis Treatment - newswit
DKSH Thailand and Bayer Thai Expand Strategic Partnership to Broaden Access to Endometriosis Treatment newswit
Published: April 2, 2026, 2:01 p.m.
Single-Dose Bioequivalence Study of Elagolix Tablets 200 mg (Test Product) and Elagolix Tablets 200 mg (Reference Product) in Healthy Non-Pregnant, Non-Lactating Premenopausal Female Subjects Under Fasting Conditions.
Elagolix is a short-acting oral gonadotropin-releasing hormone antagonist utilized for treating endometriosis-associated pain by rapidly suppressing gonadotropins and estradiol. Although well characterized in Western populations, clinical data regarding its use …
Published: April 2, 2026, midnight
Thoracic endometriosis in an inoperable patient.
In this case report, we present a case of a woman in her 30s who was diagnosed with thoracic endometriosis presenting as a large pulmonary mass. Hormonal treatment progestin (synthetic …
Published: April 2, 2026, midnight
What is endometriosis and how is it treated? UAE doctors explain myths and diagnoses - Gulf News
What is endometriosis and how is it treated? UAE doctors explain myths and diagnoses Gulf News
Published: April 1, 2026, 12:02 p.m.
What is endometriosis and how is it treated? UAE doctors explain myths and diagnoses - gulfnews.com
What is endometriosis and how is it treated? UAE doctors explain myths and diagnoses gulfnews.com
Published: April 1, 2026, 12:02 p.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - Femtech Insider
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment Femtech Insider
Published: April 1, 2026, 11:54 a.m.
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment - femtechinsider.com
Gesynta Pharma Doses First Patient in Phase 2 Trial of Non-Hormonal, Non-Opioid Endometriosis Treatment femtechinsider.com
Published: April 1, 2026, 11:54 a.m.
NICE recommends new dedicated fertility treatment pathway for endometriosis - Wired-Gov
NICE recommends new dedicated fertility treatment pathway for endometriosis Wired-Gov
Published: April 1, 2026, 8:18 a.m.
NICE recommends new dedicated fertility treatment pathway for endometriosis - wired-gov.net
NICE recommends new dedicated fertility treatment pathway for endometriosis wired-gov.net
Published: April 1, 2026, 8:18 a.m.
Link copied to clipboard!